Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy

We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery.

Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at the School of Pharmacy Queen’s University Belfast (Prof Karl Malcolm, Dr Katharina Edkins, Dr Louise Carson and Prof Helen McCarthy.

Further details on the project can be found at the link below:

Related News